CASE REPORT
Ocular coherence tomography findings in a caseof choroideremia
Savleen Kaur • Nishant Sachdev
Received: 7 December 2012 / Accepted: 18 March 2013 / Published online: 29 March 2013
� Springer Science+Business Media Dordrecht 2013
Introduction
Choroideremia is an X-linked progressive chorioret-
inal dystrophy [1]. It usually affects males who
develop early-onset night blindness, restriction of the
peripheral visual field, and a decrease in central visual
acuity, leading to blindness in the advanced stages of
the disease. Fundus examination shows a progressive
atrophy of the choroid and retinal pigment epithelium.
Spectral-domain optical coherence tomography
(SD-OCT) is the latest modality for the morphological
analysis of the retinal layers. Due to the paucity of data
on the OCT analysis of choroideremia (method of
search: pubmed) we decided to carry out a similar
study in our patient.
Case report
A 22-year-old old male presented to our out-patient
department with a history of nyctalopia and decreased
central vision. Visual fields demonstrated variable
peripheral field restriction, and due to the character-
istic fundus findings (including choroidal and retinal
pigment epithelium degenerative changes throughout
the posterior pole and mid-peripheral retina) a diag-
nosis of choroideremia was made (Fig. 1, 2).
SD-OCT revealed increased retinal thickening
(mean retinal thickness 420 lm) and cystic spaces in
the retina in both eyes (Fig. 3). The cystic spaces
ranged from small cysts in the outer plexiform layer to
huge cysts confirming cystoid macular edema (CME).
Clinical examination failed to detect cystic spaces.
Discussion
Earlier reports of choroideremia revealed a positive
correlation between retinal thickness and choriocap-
illaris preservation and advanced stages being marked
by chorioretinal atrophy [2]. Another study revealed
subtle retinal pigment epithelium irregularities with
attenuation more pronounced outside the macular
region on OCT [3].
The presence of cystic macular changes of variable
degrees on SD-OCT with an overall prevalence of
62.5 % in at least one eye and 50 % in both eyes was
first reported in 2011 [4]. Cystic changes ranging from
microcysts to diffuse macular edema along with
rosette-like structures were found in some patients.
The authors were unable to find any previous reports
of choroideremia (Fig. 3).
S. Kaur � N. Sachdev
PGIMER, Chandigarh, Punjab, India
S. Kaur (&)
47 Shakti Nagar, Jalandhar 144001, Punjab, India
e-mail: [email protected]
123
Int Ophthalmol (2014) 34:297–299
DOI 10.1007/s10792-013-9767-x
Although previous studies were performed using
time-domain OCT testing on choroideremia patients
and carriers, these noted the presence of retinal
thickening but did not show any evidence of CME
[2, 5].
We similarly observed that the central foveal
thickness in our patients was thicker and wondered
why CME occurred in choroideremia It could be due
to the macular edema itself indicating a breach in the
blood–retinal barrier or it may be related to retinal
gliosis as has been previously described by MacDon-
ald et al. [6].
The use of high-speed, high-resolution tools such as
SD-OCT may be useful to measure macular thickness
in patients suspected of having choroideremia. As
there is only one similar study commenting on CME in
choroideremia [4], we need to increase the awareness
regarding the high likelihood of finding CME in such
patients. We support the fact that once we discover
CME in such patients, we can aim at decreasing
macular edema in these patients by pharmacological
therapy and thus potentially increase their vision.
During patient selection, SD-OCT should be consid-
ered for diagnosing and monitoring patients with
choroideremia in future therapeutic trials. At the same
time we can screen patients who might benefit from
treatment.
Fig. 2 a, b Peripheral pigmentary changes well demonstrated
in the inferior fundus with variable areas of patchy chorioretinal
atrophy
Fig. 1 Fundus photograph of the posterior pole of the patient in
Fig. 3
298 Int Ophthalmol (2014) 34:297–299
123
References
1. McCulloch C, McCulloch RJP (1948) A hereditary and
clinical study of choroideremia. Trans Am Acad Ophthalmol
Otolaryngol 52:160–190
2. Jacobson SG, Cideciyan AV, Sumaroka A et al (2006) Remod-
eling of the human retina in choroideremia: rab escort protein 1
(REP-1) mutations. Invest Ophthalmol Vis Sci 47(9):4113–4120
3. Thobani A, Anastasakis A, Fishman GA (2010) Microperi-
metry and OCT findings in female carriers of choroideremia.
Ophthalmic Genet 31(4):235–239
4. Genead MA, Fishman GA (2011) Cystic macular oedema on
spectral-domain optical coherence tomography in choroi-
deremia patients without cystic changes on fundus exami-
nation. Eye 25(1):84–90
5. Mura M, Sereda C, Jablonski MM (2007) Clinical and
functional findings in choroideremia due to complete deletion
of the CHM gene. Arch Ophthalmol 125(8):1107–1113
6. MacDonald IM, Russell L, Chan CC (2009) Choroideremia:
new findings from ocular pathology and review of recent
literature. Surv Ophthalmol 54(3):401–407
Fig. 3 SD-OCT of a young male patient diagnosed with choroideremia revealing the location of the macular cysts which were mostly
at the level of the outer retinal layers in the outer plexiform and the inner nuclear layers
Int Ophthalmol (2014) 34:297–299 299
123